Target intelligence / Profile preview

MicroRNA 6816 (MIR6816)

Target
MIR6816
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

MicroRNA 6816 (MIR6816, hsa-mir-6816) appears to be a putative or uncharacterized human microRNA, for which there is currently no substantial or validated experimental information available in major genomic or bibliographic databases. MicroRNAs are small, non-coding RNAs extensively involved in post-transcriptional gene regulation, typically by binding to complementary sequences on target mRNAs to repress translation or induce degradation[1][2][3][4]. However, no sequence, annotation, target, or disease association is documented for MIR6816. Its mention may arise from computational predictions, database artifact, or mistaken transcription of another microRNA ID. As of September 2025, it is not possible to ascribe specific biological or clinical relevance to this entry.

Other names
hsa-mir-6816MIR6816microRNA mir-6816
02

Mechanism of action

Not applicable for MIR6816. Generally, microRNAs act via incorporation into the RNA-induced silencing complex (RISC), which guides Ago2-mediated mRNA repression[1][3]. But no MoA is specified for MIR6816.

03

Biological functions

microRNAs, in general, regulate gene expression at the post-transcriptional level via mRNA degradation or translation inhibitionNo specific biological function is attributed to MIR6816.
04

Disease associations

No specific association or role documented for microRNA 6816 in cancer, inflammation, neurodegenerative disease, cardiovascular disease, infection, or other pathologies. In general, microRNAs play broad roles in disease, most notably in cancer and gene regulation, but nothing is attributed to MIR6816 specifically.
05

Safety considerations

None known. No data is available regarding safety risks or therapeutic challenges associated with MIR6816.
06

Interacting drugs

None known. No drugs are documented to target or interact with MIR6816. No antisense, small molecule, or oligonucleotide therapeutics are reported against this microRNA.
07

Biomarkers

None known. No evidence supports use of MIR6816 as a clinical or research biomarker.

Beyond the preview

Go deeper on MicroRNA 6816 (MIR6816).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 6816 (MIR6816).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call